Ilay Caliskan, MD
RESIDENT
Pathology
School of Medicine

Publications (4)

Top publication keywords:
ReoperationSurvival RateVaccinationFemaleAdultIncidenceHumansSan FranciscoNeoplasm Recurrence, LocalSpinal Cord NeoplasmsHemangioblastomavon Hippel-Lindau DiseaseNeuromyelitis OpticaDatabases, FactualFollow-Up Studies

• CNS angiocentric stromal tumor (CAST), PDGFRA-mutant, a novel entity histologically mimicking meningioangiomatosis and radiologically correlating with giant Virchow-Robin spaces.
  Acta neuropathologica 2025 Guney E, Mirchia K, Schmid S, Capper D, Meinhardt J, Cha S, Lee H, Brathwaite C, Altman N, Sloan EA, Sayah A, McGrail K, Caliskan I, Terry M, Perez S, Bollen AW, Tihan T, Pekmezci M, Perry A
• Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations.
  Free neuropathology 2024 Caliskan I, Lu R, Szu Lyn Ding C, Sadala de Souza F, Perry A, Tihan T
• A Case With New-Onset Neuromyelitis Optica Spectrum Disorder Following COVID-19 mRNA BNT162b2 Vaccination.
  The neurologist 2022 Caliskan I, Bulus E, Afsar N, Altintas A
• Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
  Journal of neuro-oncology 2019 Yousef A, Rutkowski MJ, Yalcin CE, Eren OC, Caliskan I, Tihan T